University of Chicago Medicine Comprehensive Cancer Center | Strategic Alliance Partners

Latest from University of Chicago Medicine Comprehensive Cancer Center


TROP2 Membrane Ratio Effectively Predicts Dato-DXd Outcomes in NSCLC

September 08, 2024

An exploratory analysis from the TROPION-Lung 01 study shows that positivity for TROP2 normalized membrane ratio can be predictive for improved efficacy in patients with non–small cell lung cancer treated with datopotamab deruxtecan.